Gilead's Trodelvy triplet underwhelms, but bolsters company's phase 3 lung cancer design: exec 0 06.09.2024 21:33 Fiercepharma.com Gilead's Trodelvy triplet underwhelms, but bolsters company's phase 3 lung cancer design: exec aliu Fri, 09/06/2024 - 14:33